Clinical Trial Update: Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for adoptive T cell therapy in patients with recurrent ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer Recurrent

Snippet

Sponsor: Leiden University Medical Center | Conditions: Ovarian Cancer Recurrent | Phase 1, Phase 2 | Status: UNKNOWN